A survey of potential acceptance of 9-valent HPV vaccine among Chinese male college students

References

• Egawa N, Egawa K, Griffin H, Doorbar J. Human papillomaviruses; epithelial tropisms, and the development of neoplasia. Viruses. 2015 July 16;7(7):3863–10. doi:10.3390/v7072802.
   PubMed Web of Science ®Google Scholar
• Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, Snijders PJ, Meijer CJ, International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003 Feb 6;348(6):518–27. doi:10.1056/NEJMoa021641.
   PubMed Web of Science ®Google Scholar
• Denny L. Nine-valent human papillomavirus vaccine: great science, but will it save lives? Lancet. 2017 Nov 11;390(10108):2123–4. doi:10.1016/S0140-6736(17)32144-X.
   PubMed Web of Science ®Google Scholar
• Pils S, Joura EA. From the monovalent to the nine-valent HPV vaccine. Clin Microbiol Infect. 2015 Sep;21(9):827–33. doi:10.1016/j.cmi.2015.05.001.
   PubMed Web of Science ®Google Scholar
• American Chemical Society. HPV and cancer; [accessed 2023 Feb 15]. https://www.cancer.org/healthy/cancer-causes/infectious-agents/hpv/hpv-and-cancer-info.html.
   Google Scholar
• Woodman CB, Collins SI, Young LS. The natural history of cervical HPV infection: unresolved issues. Nat Rev Cancer. 2007 Jan;7(1):11–22. doi:10.1038/nrc2050.
   PubMed Web of Science ®Google Scholar
• Santella B, Schettino MT, Franci G, De Franciscis P, Colacurci N, Schiattarella A, Galdiero M. Microbiota and HPV: the role of viral infection on vaginal microbiota. J Med Virol. 2022 Sep;94(9):4478–84. doi:10.1002/jmv.27837.
   PubMed Web of Science ®Google Scholar
• Forman D, de Martel C, Lacey CJ, Soerjomataram I, Lortet-Tieulent J, Bruni L, Vignat J, Ferlay J, Bray F, Plummer M, et al. Global burden of human papillomavirus and related diseases. Vaccine. 2012 Nov 20;30(Suppl 5):F12–23. doi:10.1016/j.vaccine.2012.07.055.
   PubMedGoogle Scholar
• Huh WK, Joura EA, Giuliano AR, Iversen OE, de Andrade RP, Ault KA, Bartholomew D, Cestero RM, Fedrizzi EN, Hirschberg AL, et al. Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial. Lancet. 2017 Nov 11;390(10108):2143–59. doi:10.1016/S0140-6736(17)31821-4.
   PubMed Web of Science ®Google Scholar
• Zou Z, Fairley CK, Ong JJ, Hocking J, Canfell K, Ma X, Chow EPF, Xu X, Zhang L, Zhuang G. Domestic HPV vaccine price and economic returns for cervical cancer prevention in China: a cost-effectiveness analysis. Lancet Glob Health. 2020 Oct;8(10):e1335–e44. doi:10.1016/S2214-109X(20)30277-1.
   PubMed Web of Science ®Google Scholar
• Garland SM. Prevention strategies against human papillomavirus in males. Gynecol Oncol. 2010 May;117(2 Suppl):S20–5. doi:10.1016/j.ygyno.2010.01.027.
   PubMed Web of Science ®Google Scholar
• Harder T, Wichmann O, Klug SJ, van der Sande MAB, Wiese-Posselt M. Efficacy, effectiveness and safety of vaccination against human papillomavirus in males: a systematic review. BMC Med. 2018 Jul 18;16(1):110. doi:10.1186/s12916-018-1098-3.
   PubMedGoogle Scholar
• World Health Organization. Vaccination: European commission and world health organization join forces to promote the benefits of vaccines; [accessed 2023 Feb 15]. https://www.who.int/news/item/12-09-2019-vaccination-european-commission-and-world-health-organization-join-forces-to-promote-the-benefits-of-vaccines.
   Google Scholar
• You D, Han L, Li L, Hu J, Zimet GD, Alias H, Danaee M, Cai L, Zeng F, Wong LP. Human papillomavirus (HPV) vaccine uptake and the willingness to receive the HPV vaccination among female college students in China: a multicenter study. Vaccines (Basel). 2020 Jan 16;8(1):31. doi:10.3390/vaccines8010031.
   PubMed Web of Science ®Google Scholar
• Si M, Jiang Y, Su X, Wang W, Zhang X, Gu X, Ma L, Li J, Zhang S, Ren Z, et al. Willingness to accept human papillomavirus vaccination and its influencing factors using information-motivation-behavior skills model: a cross-sectional study of female college freshmen in mainland China. Cancer Control. 2021 Jan-Dec;28:10732748211032899. doi:10.1177/10732748211032899.
   Web of Science ®Google Scholar
• Lin Y, Lin Z, He F, Hu Z, Zimet GD, Alias H, Wong LP. Factors influencing intention to obtain the HPV vaccine and acceptability of 2-, 4- and 9-valent HPV vaccines: a study of undergraduate female health sciences students in Fujian, China. Vaccine. 2019 Oct 16;37(44):6714–23. doi:10.1016/j.vaccine.2019.09.026.
   PubMed Web of Science ®Google Scholar
• Gu C, Niccolai LM, Yang S, Wang X, Tao L. Human papillomavirus vaccine acceptability among female undergraduate students in China: the role of knowledge and psychosocial factors. J Clin Nurs. 2015 Oct;24(19–20):2765–78. doi:10.1111/jocn.12871.
   PubMed Web of Science ®Google Scholar
• Hong J, Pan B, Jiang HJ, Zhang QM, Xu XW, Jiang H, Ye JE, Cui Y, Yan XJ, Zhai XF, et al. The willingness of Chinese healthcare workers to receive monkeypox vaccine and its independent predictors: a cross-sectional survey. J Med Virol. 2023 Jan;95(1):e28294. doi:10.1002/jmv.28294.
   PubMed Web of Science ®Google Scholar
• Hong J, Xu XW, Yang J, Zheng J, Dai SM, Zhou J, Zhang QM, Ruan Y, Ling CQ. Knowledge about, attitude and acceptance towards, and predictors of intention to receive the COVID-19 vaccine among cancer patients in Eastern China: a cross-sectional survey. J Integr Med. 2022 Jan;20(1):34–44. doi:10.1016/j.joim.2021.10.004.
   PubMedGoogle Scholar
• Sari Y, Anam A, Sumeru A, Sutrisna E. The knowledge, attitude, practice and predictors of complementary and alternative medicine use among type 2 diabetes mellitus patients in Indonesia. J Integr Med. 2021 Jul;19(4):347–53. doi:10.1016/j.joim.2021.04.001.
   PubMedGoogle Scholar
• Adjei Boakye E, Tobo BB, Rojek RP, Mohammed KA, Geneus CJ, Osazuwa-Peters N. Approaching a decade since HPV vaccine licensure: racial and gender disparities in knowledge and awareness of HPV and HPV vaccine. Hum Vaccin Immunother. 2017 Nov 2;13(11):2713–22. doi:10.1080/21645515.2017.1363133.
   PubMed Web of Science ®Google Scholar
• Liu Y, Di N, Tao X. Knowledge, practice and attitude towards HPV vaccination among college students in Beijing, China. Hum Vaccin Immunother. 2020;16(1):116–23. doi:10.1080/21645515.2019.1638727.
   PubMed Web of Science ®Google Scholar
• Farsi NJ, Baharoon AH, Jiffri AE, Marzouki HZ, Merdad MA, Merdad LA. Human papillomavirus knowledge and vaccine acceptability among male medical students in Saudi Arabia. Hum Vaccin Immunother. 2021 Jul 3;17(7):1968–74. doi:10.1080/21645515.2020.1856597.
   PubMed Web of Science ®Google Scholar
• Petrosky E, Bocchini JA Jr, Hariri S, Chesson H, Curtis CR, Saraiya M, Unger ER, Markowitz LE. Centers for disease control and prevention (CDC). Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. Morb Mortal Wkly Rep. 2015 Mar 27;64(11):300–4.
   PubMed Web of Science ®Google Scholar
• Mascaro V, Pileggi C, Currà A, Bianco A, Pavia M. HPV vaccination coverage and willingness to be vaccinated among 18-30 year-old students in Italy. Vaccine. 2019 May 31;37(25):3310–6. doi:10.1016/j.vaccine.2019.04.081.
   PubMed Web of Science ®Google Scholar
• Choi JS, Park S. A study on the predictors of Korean male students’ intention to receive human papillomavirus vaccination. J Clin Nurs. 2016 Nov;25(21–22):3354–62. doi:10.1111/jocn.13461.
   PubMed Web of Science ®Google Scholar
• Hernandez BY, Wilkens LR, Thompson PJ, Shvetsov YB, Goodman MT, Ning L, Kaopua L. Acceptability of prophylactic human papillomavirus vaccination among adult men. Hum Vaccin. 2010 Jun;6(6):467–75. doi:10.4161/hv.6.6.11279.
   PubMed Web of Science ®Google Scholar
• Daley EM, Marhefka SL, Buhi ER, Vamos CA, Hernandez ND, Giuliano AR. Human papillomavirus vaccine intentions among men participating in a human papillomavirus natural history study versus a comparison sample. Sex Transm Dis. 2010 Oct;37(10):644–52. doi:10.1097/OLQ.0b013e3181e1a14c.
   PubMed Web of Science ®Google Scholar
• Lenselink CH, Schmeink CE, Melchers WJ, Massuger LF, Hendriks JC, van Hamont D, Bekkers RL. Young adults and acceptance of the human papillomavirus vaccine. Public Health. 2008 Dec;122(12):1295–301. doi:10.1016/j.puhe.2008.02.010.
   PubMed Web of Science ®Google Scholar
• Zhou L, Gu B, Xu X, Li Y, Cheng P, Huo Y, Liu G, Zhang X. On imported and domestic human papillomavirus vaccines: cognition, attitude, and willingness to pay in Chinese medical students. Front Public Health. 2022 May 12;10:863748. doi:10.3389/fpubh.2022.863748.
   PubMed Web of Science ®Google Scholar
• Xu Y, Bi W, Liu T, Jiang Y, Wang Q, Fan R. Factors associated with intention of human papillomavirus vaccination among Chinese college students: implications for health promotion. Hum Vaccin Immunother. 2021 Dec 2;17(12):5426–32. doi:10.1080/21645515.2021.2007014.
   PubMed Web of Science ®Google Scholar
• Young AM, Crosby RA, Jagger KS, Casquejo E, Pinote L, Ybañez P, Casquejo L, Estorgio D, Pinote L. Influences on HPV vaccine acceptance among men in the Philippines. J Men’s Health. 2011 May;8(2):126–35. doi:10.1016/j.jomh.2011.01.007.
   Web of Science ®Google Scholar
• Bonafide KE, Vanable PA. Male human papillomavirus vaccine acceptance is enhanced by a brief intervention that emphasizes both male-specific vaccine benefits and altruistic motives. Sex Transm Dis. 2015 Feb;42(2):76–80. doi:10.1097/OLQ.0000000000000226.
   PubMed Web of Science ®Google Scholar
• Donahue KL, Hendrix KS, Sturm LA, Zimet GD. Human papillomavirus vaccine initiation among 9-13-Year-olds in the United States. Prev Med Rep. 2015;2:892–8. doi:10.1016/j.pmedr.2015.10.003.
   PubMedGoogle Scholar
• Dai Z, Si M, Su X, Wang W, Zhang X, Gu X, Ma L, Li J, Zhang S, Ren Z, et al. Willingness to human papillomavirus (HPV) vaccination and influencing factors among male and female university students in China. J Med Virol. 2022 Jun;94(6):2776–86. doi:10.1002/jmv.27478.
   PubMed Web of Science ®Google Scholar
• Ma Y, Wang C, Liu F, Lian G, Li S, He Q, Li T. Human papillomavirus vaccination coverage and knowledge, perceptions and influencing factors among university students in Guangzhou, China. Hum Vaccin Immunother. 2021 Oct 3;17(10):3603–12. doi:10.1080/21645515.2021.1927411.
   PubMed Web of Science ®Google Scholar
• Zhang X, Wang Z, Ren Z, Li Z, Ma W, Gao X, Zhang R, Qiao Y, Li J. HPV vaccine acceptability and willingness-related factors among Chinese adolescents: a nation-wide study. Hum Vaccin Immunother. 2021 Apr 3;17(4):1025–32. doi:10.1080/21645515.2020.1812314.
   PubMed Web of Science ®Google Scholar
• Chiang VC, Wong HT, Yeung PC, Choi YK, Fok MS, Mak OI, Wong HY, Wong KH, Wong SY, Wong YS, et al. Attitude, acceptability and knowledge of HPV vaccination among Local University students in Hong Kong. Int J Environ Res Public Health. 2016 May 11;13(5):486. doi:10.3390/ijerph13050486.
   PubMed Web of Science ®Google Scholar
• Jones M, Cook R. Intent to receive an HPV vaccine among university men and women and implications for vaccine administration. J Am Coll Health. 2008 Jul-Aug;57(1):23–32. doi:10.3200/JACH.57.1.23-32.
   PubMed Web of Science ®Google Scholar
• Laserson AK, Oliffe JL, Krist J, Kelly MT. HPV vaccine and college-age men: a scoping review. Am J Mens Health. 2020 Nov-Dec;14(6):1557988320973826. doi:10.1177/1557988320973826.
   Web of Science ®Google Scholar
• Sadlier C, Lynam A, O’Dea S, Delamere S, Quinlan M, Clarke S, Sheils O, Bergin C. HPV vaccine acceptability in HIV-infected and HIV negative men who have sex with men (MSM) in Ireland. Hum Vaccin Immunother. 2016 Jun 2;12(6):1536–41. doi:10.1080/21645515.2016.1151588.
   PubMed Web of Science ®Google Scholar
• Giuliani M, Vescio MF, Donà MG, Latini A, Frasca M, Colafigli M, Farinella M, Rezza G, Cristaudo A. Perceptions of human papillomavirus (HPV) infection and acceptability of HPV vaccine among men attending a sexual health clinic differ according to sexual orientation. Hum Vaccin Immunother. 2016 Jun 2;12(6):1542–50. doi:10.1080/21645515.2015.1115935.
   PubMed Web of Science ®Google Scholar
• Oh JK, Lim MK, Yun EH, Lee EH, Shin HR. Awareness of and attitude towards human papillomavirus infection and vaccination for cervical cancer prevention among adult males and females in Korea: a nationwide interview survey. Vaccine. 2010 Feb 17;28(7):1854–60. doi:10.1016/j.vaccine.2009.11.079.
   PubMed Web of Science ®Google Scholar
• Van Damme P, Meijer CJLM, Kieninger D, Schuyleman A, Thomas S, Luxembourg A, Baudin M. A phase III clinical study to compare the immunogenicity and safety of the 9-valent and quadrivalent HPV vaccines in men. Vaccine. 2016 Jul 29;34(35):4205–12. doi:10.1016/j.vaccine.2016.06.056.
   PubMed Web of Science ®Google Scholar
• Reiter PL, Brewer NT, Smith JS. Human papillomavirus knowledge and vaccine acceptability among a national sample of heterosexual men. Sex Transm Infect. 2010 Jun;86(3):241–6. doi:10.1136/sti.2009.039065.
   PubMed Web of Science ®Google Scholar
• Tatar O, Shapiro GK, Perez S, Wade K, Rosberger Z. Using the precaution adoption process model to clarify human papillomavirus vaccine hesitancy in canadian parents of girls and parents of boys. Hum Vaccin Immunother. 2019;15(7–8):1803–14. doi:10.1080/21645515.2019.1575711.
   PubMed Web of Science ®Google Scholar
• Hu S, Xu X, Zhang Y, Liu Y, Yang C, Wang Y, Wang Y, Yu Y, Hong Y, Zhang X, et al. A nationwide post-marketing survey of knowledge, attitude and practice toward human papillomavirus vaccine in general population: implications for vaccine roll-out in mainland China. Vaccine. 2021 Jan 3;39(1):35–44. doi:10.1016/j.vaccine.2020.11.029.
   PubMed Web of Science ®Google Scholar